Browsing Tag
Peter MacCallum Cancer Centre
2 posts
Nuvalent (NUVL) brings full ALKOVE-1 dataset to ASCO 2026 oral session weeks after neladalkib FDA filing
Nuvalent (NUVL) brings pivotal ALKOVE-1 neladalkib data to ASCO 2026. Here's what the oral session means for its dual NDA strategy and ALK lung cancer treatment.
April 21, 2026
Semaphore Solutions secures new investment to accelerate Labbit’s AI-driven expansion
Discover how Semaphore Solutions' Labbit is transforming laboratory operations with agentic AI after a new round of funding from Cypress Ridge Capital.
April 1, 2025